US Stock MarketDetailed Quotes

GLUE Monte Rosa Therapeutics

Watchlist
  • 7.050
  • +0.010+0.14%
Close Mar 28 16:00 ET
  • 7.050
  • 0.0000.00%
Post 16:16 ET
353.59MMarket Cap-2680P/E (TTM)

About Monte Rosa Therapeutics Company

Monte Rosa Therapeutics, Inc. operates as a biotechnology company focused on developing precision medicines. The company was founded on November 21, 2019 and is headquartered in Boston, MA.

Company Profile

SymbolGLUE
Company NameMonte Rosa Therapeutics
Listing Date06/24/2021
Issue Price19.00
Founded2019
CEOMr. Markus Warmuth
MarketNASDAQ
Employees133
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address321 Harrison Avenue,Suite 900
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02118
Phone1-617-949-2643

Company Executives

  • Name
  • Position
  • Salary
  • Markus Warmuth
  • Director, Chief Executive Officer and President
  • 3.81M
  • Dr. Owen Wallace, PhD
  • Chief Scientific Officer
  • 1.71M
  • Ajim Tamboli, C.F.A.
  • Chief Financial Officer and Principal Accounting Officer
  • --
  • Dr. Filip Janku, M.D.
  • Chief Medical Officer
  • 2.05M
  • Dr. Jullian G. Jones
  • Chief Business Officer
  • --
  • Edmund Dunn
  • Principal Accounting Officer, Vice President and Corporate Controller
  • --
  • Dr. Alexander Mayweg, PhD
  • Chairman of the Board
  • 147.92K
  • Dr. Jan Skvarka
  • Director
  • --
  • Dr. Ali Behbahani, M.B.A.,M.D.
  • Independent Director
  • 122.92K
  • Dr. Anthony M. Manning, PhD
  • Independent Director
  • --
  • Christine Siu
  • Independent Director
  • 132.92K
  • Dr. Kimberly L. Blackwell, M.D.
  • Independent Director
  • 122.92K
  • Philip Nickson
  • General Counsel
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg